Lavender Bina Cendikia Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Lavender Bina Cendikia Tbk. trades at Rp32 (market cap 32.96B, 655K 24h volume), while Prodia Diagnostic Line Tbk trades at Rp270 (market cap 470.58B, 28.43M 24h volume). The key difference: Prodia Diagnostic Line Tbk is far larger — about 14.3× Lavender Bina Cendikia Tbk.'s market cap, and Prodia Diagnostic Line Tbk is more actively traded (28.43M versus 655K). Which is the better fit depends on your goals.
| BMBL | PRDL | |
|---|---|---|
Market Cap | 32.96B | 470.58B |
Volume | 655K | 28.43M |
Lot | 6.55K | 284.34K |
Turnover | 20.3M | 7.8B |
Average Price | 30.99 | 274.19 |
Value | 20.3M | 7.8B |
Indicative Equilibrium Price | 32 | 270 |
Indicative Equilibrium Volume | 10 | 2.1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Lavender Bina Cendikia Tbk ("Company") was established on November 27, 2013 based on theNotarial deed of Suparman Hasyim, S.H., No. 35. The Company started its commercial operations in2013. The ultimate beneficial owner of the Company is Galih Pandekar.
Read more on BMBL →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →